| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer
|
Fohlin, Helena
|
|
2013
|
49 |
6 |
p. 1196-1204
9 p.
|
article
|
| 2 |
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
|
Sternberg, Cora N.
|
|
2013
|
49 |
6 |
p. 1287-1296
10 p.
|
article
|
| 3 |
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
|
Ferlay, J.
|
|
2013
|
49 |
6 |
p. 1374-1403
30 p.
|
article
|
| 4 |
Cancer rehabilitation indicators for Europe
|
Baili, Paolo
|
|
2013
|
49 |
6 |
p. 1356-1364
9 p.
|
article
|
| 5 |
Childhood acute lymphoblastic leukaemia and birthweight: Insights from a pooled analysis of case–control data from Germany, the United Kingdom and the United States
|
Roman, Eve
|
|
2013
|
49 |
6 |
p. 1437-1447
11 p.
|
article
|
| 6 |
Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
|
Lee, Hee Eun
|
|
2013
|
49 |
6 |
p. 1448-1457
10 p.
|
article
|
| 7 |
Deregulation of protein methylation in melanoma
|
Limm, Katharina
|
|
2013
|
49 |
6 |
p. 1305-1313
9 p.
|
article
|
| 8 |
Description of selected characteristics of familial glioma patients – Results from the Gliogene Consortium
|
Sadetzki, Siegal
|
|
2013
|
49 |
6 |
p. 1335-1345
11 p.
|
article
|
| 9 |
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients
|
Vincenzi, Bruno
|
|
2013
|
49 |
6 |
p. 1501-1508
8 p.
|
article
|
| 10 |
Effects of erlotinib first-line maintenance therapy versus placebo on the health-related quality of life of patients with metastatic non-small-cell lung cancer
|
Juhász, Erzsébet
|
|
2013
|
49 |
6 |
p. 1205-1215
11 p.
|
article
|
| 11 |
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
|
Ducreux, M.
|
|
2013
|
49 |
6 |
p. 1236-1245
10 p.
|
article
|
| 12 |
Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer
|
Therkildsen, Christina
|
|
2013
|
49 |
6 |
p. 1226-1235
10 p.
|
article
|
| 13 |
Gonadal function recovery in very long-term male survivors of childhood cancer
|
van Dorp, Wendy
|
|
2013
|
49 |
6 |
p. 1280-1286
7 p.
|
article
|
| 14 |
High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
|
Flammiger, Anna
|
|
2013
|
49 |
6 |
p. 1273-1279
7 p.
|
article
|
| 15 |
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer
|
Tan, David S.P.
|
|
2013
|
49 |
6 |
p. 1246-1253
8 p.
|
article
|
| 16 |
Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databases
|
Walker, Alex J.
|
|
2013
|
49 |
6 |
p. 1404-1413
10 p.
|
article
|
| 17 |
Interactions between MAP kinase and oestrogen receptor in human breast cancer
|
McGlynn, Liane M.
|
|
2013
|
49 |
6 |
p. 1176-1186
11 p.
|
article
|
| 18 |
Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies
|
van der Rhee, Han
|
|
2013
|
49 |
6 |
p. 1422-1436
15 p.
|
article
|
| 19 |
Local control and sequelae in localised Ewing tumours of the spine: A French retrospective study
|
Vogin, Guillaume
|
|
2013
|
49 |
6 |
p. 1314-1323
10 p.
|
article
|
| 20 |
Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer
|
van der Burg, M.E.L.
|
|
2013
|
49 |
6 |
p. 1254-1263
10 p.
|
article
|
| 21 |
Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome
|
Malouf, Gabriel G.
|
|
2013
|
49 |
6 |
p. 1324-1334
11 p.
|
article
|
| 22 |
Mindfulness significantly reduces self-reported levels of anxiety and depression: Results of a randomised controlled trial among 336 Danish women treated for stage I–III breast cancer
|
Würtzen, Hanne
|
|
2013
|
49 |
6 |
p. 1365-1373
9 p.
|
article
|
| 23 |
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia – Long-term results of trial ALL-REZ BFM P95/96
|
Eckert, Cornelia
|
|
2013
|
49 |
6 |
p. 1346-1355
10 p.
|
article
|
| 24 |
Mothers’ screening histories influence daughters’ vaccination uptake: An analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England
|
Spencer (nee Pilkington), Angela M.
|
|
2013
|
49 |
6 |
p. 1264-1272
9 p.
|
article
|
| 25 |
New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: The role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasome
|
Fratelli, Maddalena
|
|
2013
|
49 |
6 |
p. 1491-1500
10 p.
|
article
|
| 26 |
Outcome of second-line chemotherapy for biliary tract cancer
|
Bridgewater, John
|
|
2013
|
49 |
6 |
p. 1511-
1 p.
|
article
|
| 27 |
Population-based survival of penile cancer patients in Europe and the United States of America: No improvement since 1990
|
Verhoeven, R.H.A.
|
|
2013
|
49 |
6 |
p. 1414-1421
8 p.
|
article
|
| 28 |
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies
|
Licitra, Lisa
|
|
2013
|
49 |
6 |
p. 1161-1168
8 p.
|
article
|
| 29 |
Renal tumours in a Tsc1 +/– mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
|
Yang, Jian
|
|
2013
|
49 |
6 |
p. 1479-1490
12 p.
|
article
|
| 30 |
Resistance to BRAF-targeted therapy in melanoma
|
Sullivan, Ryan J.
|
|
2013
|
49 |
6 |
p. 1297-1304
8 p.
|
article
|
| 31 |
Response to letter ‘Outcome of second-line chemotherapy for biliary tract cancer’
|
Walter, Thomas
|
|
2013
|
49 |
6 |
p. 1512-1513
2 p.
|
article
|
| 32 |
Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer
|
Infante, Jeffrey R.
|
|
2013
|
49 |
6 |
p. 1169-1175
7 p.
|
article
|
| 33 |
Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: Molecular whole-node analysis of all removed nodes
|
Osako, Tomo
|
|
2013
|
49 |
6 |
p. 1187-1195
9 p.
|
article
|
| 34 |
Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years
|
Cufer, Tanja
|
|
2013
|
49 |
6 |
p. 1216-1225
10 p.
|
article
|
| 35 |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai, Yu-Chieh
|
|
2013
|
49 |
6 |
p. 1458-1466
9 p.
|
article
|
| 36 |
Tissue redox activity as a sensing platform for imaging of cancer based on nitroxide redox cycle
|
Zhelev, Zhivko
|
|
2013
|
49 |
6 |
p. 1467-1478
12 p.
|
article
|
| 37 |
Transarterial chemoembolisation is not superior to embolisation alone: The recent European Association for the Study of the Liver (EASL)–European Organisation for Research and Treatment of Cancer (EORTC) guidelines
|
Tsochatzis, Emmanuel
|
|
2013
|
49 |
6 |
p. 1509-1510
2 p.
|
article
|
Journal description